Biomaterial Database

Coxiella burnetii endocarditis in a child. 1997

S al-Hajjar, and S M Hussain Qadri, and E al-Sabban, and C Jäger

Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

UI	MeSH Term	Description	Entries
D008297	Male		Males
D011778	Q Fever	An acute infectious disease caused by COXIELLA BURNETII. It is characterized by a sudden onset of FEVER; HEADACHE; malaise; and weakness. In humans, it is commonly contracted by inhalation of infected dusts derived from infected domestic animals (ANIMALS, DOMESTIC).	Coxiella burnetii Fever,Query Fever,Acute Q Fever,Chronic Q Fever,Coxiella burnetii Infection,Coxiella burnetii Vector-Borne Disease,Acute Q Fevers,Chronic Q Fevers,Coxiella burnetii Fevers,Coxiella burnetii Infections,Coxiella burnetii Vector Borne Disease,Fever, Acute Q,Fever, Chronic Q,Fever, Coxiella burnetii,Fever, Q,Fever, Query,Fevers, Acute Q,Fevers, Chronic Q,Fevers, Coxiella burnetii,Fevers, Q,Fevers, Query,Infection, Coxiella burnetii,Infections, Coxiella burnetii,Q Fever, Acute,Q Fever, Chronic,Q Fevers,Q Fevers, Acute,Q Fevers, Chronic,Query Fevers
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D003131	Combined Modality Therapy	The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.	Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003937	Diagnosis, Differential	Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures.	Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004359	Drug Therapy, Combination	Therapy with two or more separate preparations given for a combined effect.	Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004697	Endocarditis, Bacterial	Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use.	Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D006350	Heart Valve Prosthesis	A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material.	Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA.	Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

S al-Hajjar, and S M Hussain Qadri, and E al-Sabban, and C Jäger

Coxiella burnetii Endocarditis in a Child Caused by a New Genotype.

February 2016, The Pediatric infectious disease journal,

S al-Hajjar, and S M Hussain Qadri, and E al-Sabban, and C Jäger

[Drug treatment of Coxiella burnetii endocarditis].

July 2000, Medicina clinica,

S al-Hajjar, and S M Hussain Qadri, and E al-Sabban, and C Jäger

Glomerulonephritis associated with Coxiella burnetii endocarditis.

February 1975, British medical journal,

S al-Hajjar, and S M Hussain Qadri, and E al-Sabban, and C Jäger

Coinfection with Coxiella burnetii in infectious endocarditis.

December 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,

S al-Hajjar, and S M Hussain Qadri, and E al-Sabban, and C Jäger

Coxiella burnetii endocarditis after Q fever vaccination.

December 2012, Journal of medical microbiology,

S al-Hajjar, and S M Hussain Qadri, and E al-Sabban, and C Jäger

Infective aortic valve endocarditis from Coxiella burnetii.

January 2007, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese,

S al-Hajjar, and S M Hussain Qadri, and E al-Sabban, and C Jäger

Coxiella burnetii myopericarditis and rhabdomyolysis in a child.

November 2000, The Pediatric infectious disease journal,

S al-Hajjar, and S M Hussain Qadri, and E al-Sabban, and C Jäger

Coxiella Burnetii Endocarditis In A Patient With Mycotic Cerebral Aneurysms.

February 2024, Portuguese journal of cardiac thoracic and vascular surgery,